Intravitreal injection of AAV2 transduces macaque inner retina.

PURPOSE Adeno-associated virus serotype 2 (AAV2) has been shown to be effective in transducing inner retinal neurons after intravitreal injection in several species. However, results in nonprimates may not be predictive of transduction in the human inner retina, because of differences in eye size and the specialized morphology of the high-acuity human fovea. This was a study of inner retina transduction in the macaque, a primate with ocular characteristics most similar to that of humans. METHODS In vivo imaging and histology were used to examine GFP expression in the macaque inner retina after intravitreal injection of AAV vectors containing five distinct promoters. RESULTS AAV2 produced pronounced GFP expression in inner retinal cells of the fovea, no expression in the central retina beyond the fovea, and variable expression in the peripheral retina. AAV2 vector incorporating the neuronal promoter human connexin 36 (hCx36) transduced ganglion cells within a dense annulus around the fovea center, whereas AAV2 containing the ubiquitous promoter hybrid cytomegalovirus (CMV) enhancer/chicken-β-actin (CBA) transduced both Müller and ganglion cells in a dense circular disc centered on the fovea. With three shorter promoters--human synapsin (hSYN) and the shortened CBA and hCx36 promoters (smCBA and hCx36sh)--AAV2 produced visible transduction, as seen in fundus images, only when the retina was altered by ganglion cell loss or enzymatic vitreolysis. CONCLUSIONS The results in the macaque suggest that intravitreal injection of AAV2 would produce high levels of gene expression at the human fovea, important in retinal gene therapy, but not in the central retina beyond the fovea.

[1]  A. Hendrickson,et al.  Organization of the Adult Primate Fovea , 2005 .

[2]  Mark Basche,et al.  Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. , 2009, Human molecular genetics.

[3]  S. Schein.  Anatomy of macaque fovea and spatial densities of neurons in foveal representation , 1988, The Journal of comparative neurology.

[4]  S. Kügler,et al.  Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. , 2003, Virology.

[5]  Earl L. Smith,et al.  Recovery from form-deprivation myopia in rhesus monkeys. , 2004, Investigative ophthalmology & visual science.

[6]  E. Surace,et al.  Versatility of AAV vectors for retinal gene transfer , 2008, Vision Research.

[7]  Roger Lewin,et al.  Human Evolution: An Illustrated Introduction , 2004 .

[8]  A. Harvey,et al.  Gene therapy and transplantation in CNS repair: The visual system , 2006, Progress in Retinal and Eye Research.

[9]  Deniz Dalkara,et al.  Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  D. Troilo,et al.  The response to visual form deprivation differs with age in marmosets. , 2005, Investigative ophthalmology & visual science.

[11]  B. Boycott,et al.  Parasol (Pα) ganglion-cells of the primate fovea: Immunocytochemical staining with antibodies against GABAA-receptors , 1993, Vision Research.

[12]  C. Curcio,et al.  Topography of ganglion cells in human retina , 1990, The Journal of comparative neurology.

[13]  Jean Bennett,et al.  Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor. , 2005, Diabetes.

[14]  Bernard P. Gee,et al.  In vivo fluorescence imaging of primate retinal ganglion cells and retinal pigment epithelial cells. , 2006, Optics express.

[15]  R. Samulski,et al.  αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection , 1999, Nature Medicine.

[16]  A. Cowey,et al.  The ganglion cell and cone distributions in the monkey's retina: Implications for central magnification factors , 1985, Vision Research.

[17]  F. Rolling.  Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives , 2004, Gene therapy.

[18]  G. Legge,et al.  Functional and cortical adaptations to central vision loss , 2005, Visual Neuroscience.

[19]  Eduardo Fernández,et al.  Webvision: The Organization of the Retina and Visual System , 1995 .

[20]  J E Morgan,et al.  Histological measurement of retinal nerve fibre layer thickness , 2005, Eye.

[21]  M. During,et al.  Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. , 2002, Methods.

[22]  Zhuo-Hua Pan,et al.  Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina. , 2010, Investigative ophthalmology & visual science.

[23]  W. Hauswirth,et al.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  A. Kampik,et al.  Posterior vitreous detachment induced by microplasmin. , 2004, Investigative ophthalmology & visual science.

[25]  B. Matsumoto,et al.  Topographic variations in the rabbit and primate internal limiting membrane. , 1984, Investigative ophthalmology & visual science.

[26]  R. Ali,et al.  AAV-mediated gene therapy for retinal disorders: from mouse to man , 2008, Gene Therapy.

[27]  Earl L. Smith,et al.  Normal ocular development in young rhesus monkeys (Macaca mulatta) , 2007, Vision Research.

[28]  David R Williams,et al.  In vivo imaging of microscopic structures in the rat retina. , 2009, Investigative ophthalmology & visual science.

[29]  A. Harvey,et al.  Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection , 2009, Gene Therapy.

[30]  P. Fan,et al.  Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. , 1996, Human gene therapy.

[31]  D. Hunt,et al.  Adeno-associated virus gene transfer to mouse retina. Human Gene Therapy , 1998 .

[32]  R. Samulski,et al.  Infectious Entry Pathway of Adeno-Associated Virus and Adeno-Associated Virus Vectors , 2000, Journal of Virology.

[33]  D. Snodderly,et al.  Neural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis) , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  S. Kügler,et al.  Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area , 2003, Gene Therapy.

[35]  Jay Neitz,et al.  Gene therapy for red-green colour blindness in adult primates , 2009, Nature.

[36]  R. Samulski,et al.  Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.

[37]  S. Schein,et al.  A four-surface schematic eye of macaque monkey obtained by an optical method , 1995, Vision Research.

[38]  R. Samulski,et al.  AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. , 1999, Nature medicine.

[39]  E. Harrison.  Visual Acuity and the Cone Cell Distribution of the Retina * , 1953, The British journal of ophthalmology.

[40]  Keyun Qing,et al.  Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 , 1999, Nature Medicine.

[41]  T. Ogden,et al.  Nerve fiber layer of the macaque retina: retinotopic organization. , 1983, Investigative ophthalmology & visual science.

[42]  B. Byrne,et al.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.

[43]  E. Kubo,et al.  Axial length, myopia, and the severity of lens opacity at the time of cataract surgery. , 2006, Archives of ophthalmology.

[44]  R. Samulski,et al.  Selective and rapid uptake of adeno-associated virus type 2 in brain. , 1998, Human gene therapy.

[45]  Helga Kolb,et al.  Facts and Figures Concerning the Human Retina , 1995 .

[46]  T. Clackson,et al.  Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. , 2005, Human gene therapy.

[47]  Kareem M. Ahmad,et al.  Cell density ratios in a foveal patch in macaque retina , 2003, Visual Neuroscience.

[48]  Kathleen A. Marshall,et al.  Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial , 2009, The Lancet.

[49]  K. Stieger,et al.  AAV-mediated gene therapy for retinal disorders in large animal models. , 2009, ILAR journal.

[50]  B. Boycott,et al.  Cortical magnification factor and the ganglion cell density of the primate retina , 1989, Nature.

[51]  H Kolb,et al.  Facts and Figures Concerning the Human Retina -- Webvision: The Organization of the Retina and Visual System , 1995 .

[52]  Kenneth I. Berns,et al.  Gene Therapy Using Adeno-Associated Virus Vectors , 2008, Clinical Microbiology Reviews.

[53]  David R Williams,et al.  In vivo imaging of the fine structure of rhodamine-labeled macaque retinal ganglion cells. , 2008, Investigative ophthalmology & visual science.

[54]  W. Hauswirth,et al.  Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential , 2008, Molecular vision.

[55]  David Troilo,et al.  Visual optics and retinal cone topography in the common marmoset (Callithrix jacchus) , 1993, Vision Research.

[56]  C. Distler,et al.  Glia Cells of the Monkey Retina—II. Müller Cells , 1996, Vision Research.

[57]  B. Boycott,et al.  Retinal ganglion cell density and cortical magnification factor in the primate , 1990, Vision Research.

[58]  J. Flannery,et al.  Changes in adeno-associated virus-mediated gene delivery in retinal degeneration. , 2010, Human gene therapy.